About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Court Report | Main | INC Research® to Expand Services in Japan »

November 29, 2006

Dyax and CSIRO to Collaborate in Antibody Discovery

    By Jason Derry --

Dyax_hmlogo_1 Dyax Corp. and the Australian national scientific research agency, CSIRO, have announced a collaborative partnership to discover and develop antibodies for treating cancer.  Dyax will provide the antibody libraries and screen for potential clinical leads, while CSIRO will test the leads and work on developing the leads into clinically useful therapeutics.  According to its website, Dyax's mission is to generate biotherapeutics, particularly in the area of immunology and oncology.  In addition, Dyax has entered over 70 revenue-generating collaborative and licensing arrangements involving discovery, affinity separation, diagnostic imaging, and research reagents.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 01:44 PM in Biotech/Pharma Business |

Comments

The comments to this entry are closed.

September 2024

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

Categories

Archives

More...